ABVC - Company ID 0001173313
ABVC BIOPHARMA, INC. (ABVC) reported revenue of $296.00K for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $296.00K | -41.9% |
| FY 2024 | $509.59K | +234.3% |
| FY 2023 | $152.43K | -84.3% |
| FY 2022 | $969.78K | +172.6% |
| FY 2021 | $355.80K | -26.3% |
| FY 2020 | $483.05K | -31.2% |
| FY 2019 | $701.72K | +9988.0% |
| FY 2018 | $6.96K | +107.0% |
| FY 2015 |
ABVC BIOPHARMA, INC. (ABVC) reported revenue of $296.00K for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2010 and fiscal 2025, ABVC BIOPHARMA, INC.'s revenue grew from $14.86K to $296.00K.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.36K |
| - |
| FY 2014 | $0.00 | -100.0% |
| FY 2013 | $7.79K | +36.3% |
| FY 2012 | $5.71K | +79.1% |
| FY 2011 | $3.19K | -78.5% |
| FY 2010 | $14.86K | - |